Henry Levy, chief strategy officer at Veeva, has been working to transform the way the biopharmaceutical industry improves patient health for 23 years. Prior to Veeva, Henry was chief commercial officer for PPD, where he defined new models for the biotech and biopharmaceutical industry to partner with contract research organizations. These new models brought down the cost and improved the speed of drug development.
Prior to PPD, Henry led Accenture's life sciences research and development practice, helping the industry improve through consulting, technology, and outsourcing solutions. In his role, Henry worked with 90% of the top 20 biopharmaceutical companies and provided Accenture leadership to industry groups like TransCelerate and Hever. Henry has published multiple articles on clinical development and technology trends, and is a frequent speaker at industry forums. Henry holds a bachelor of science degree in bioengineering from the University of Pennsylvania.